Clinical Trial Search

Primary: Health Services Utilization 3 Months Following Hospital Discharge — 3.33; 3.40 Health Services Utilizations — p=.87

Primary: High-risk Medication Doses — 0.049; 0.052; 0.036; 0.019 No. of med orders by patient per intern

Primary: Adverse Drug Events or Potential Adverse Drug Events — 99; 104 Patient-Medication Pairs

Primary: Hospital Length of Stay — 6.8; 7.8; 7.5 Days

Primary: Usability of the SAM App — 1.14; 1.32; 1.35; 1.81 score on a scale

Primary: Time to Dispensing of Inappropriate Medication Prescription — 76.7; 77.9; 77.5 Percentage of Cumulative Incidence — p=0.76

Primary: Change in Inappropriate Prescribing by Study Arm: Descriptive Comparison Across Study Arms — 35.2; 33; 35.6; 40.6 percentage of patients

Primary: Change in Inappropriate Prescribing — 106; 145; 122 Participants — p=0.002

Primary: Medication Knowledge (0-100) — 71.2; 71.9; 73.2; 74.9 score on a scale

Primary: Any Hospitalization or Any Emergency Room Visits — 497; 574; 380; 391 Participants — p=<.001

Primary: Number of Participants With Changes in Signs and Symptoms Related to Adverse Effects of Prescribed Medicines. Clinical Gains and Benefits to Residents — 17 Participants

Primary: Medically Treated Falls — 328; 349 Participants — p=0.11

Primary: Proportion of Days Covered (PDC) — 82.6; 75.6; 78.4; 73.3 percentage of days covered

Primary: Medication Specific Knowledge — 63.82; 62.80 score (0-100)

Primary: Number of Medication Errors — 9; 20 number of medication errors

Primary: Number of Participants With Treatment-Related Adverse Events — 608 Participants

Primary: Number of Serious Medication Errors as Determined by Interview and Medical Chart Review — 0.95; 0.87 serious medication errors

Primary: Total Number of Medications — 15; 16; 13; 15 Medications — p=0.017

Primary: Primary Effectiveness Outcome - LDL — 57.9; 54.8 percentage of time spent at goal

Primary: Number of Participants With Changes/Updates in Medication List — 101; 43 Participants — p=<0.0001

Primary: The Number (Proportion) of Notifications (in the Existing-prescription Notification Conditions) That Are Addressed Within 7 Days. — 24.86; 21.74 percent of notifications

Primary: Number of Participants With Dementia With Medically Treated Falls — 24 Participants

Primary: Change in Past 6 Month Non-Medical Use of Prescription Stimulant Medication Frequency — -2.04; -1.72; -1.03; -.38 Usage days — p=0.03

Primary: Mean Severity-weighted Admission Medication History (AMH) Error Score — 23; 4.1; 4.1 Mean Severity-weighted AMH Error Score

Primary: Percentage of Potentially Inappropriate Galenic Units — 24; 23 percent — p=<0.05

Primary: Feasibility of AMDD to Improve Medication Adherence Via Completion Rate — 15 participants

Primary: The Probability of Complete Responses Over Three Cycles of Chemotherapy After the Start of the MEC Administration — 0.810; 0.718 Probability of complete response — p=<0.05

Primary: Reaction Time — 3668; 4727; 4510 millisecond (ms)

Primary: Blood Pressure Medication Adherence — 396; 470 Participants — p=0.0103

Primary: Behaviors Risk Score — 17.9; 16.6; 16.4; 12.6 units on a scale — p=0.035